NY settlement highlights risks, costs of Indivior’s overdose drug
The pharmaceutical manufacturer Indivior has stopped marketing Opvee, its controversial overdose-reversal medication, after two years of meager sales,…
New research reassures on opioid use during pregnancy and child development
An Indiana University study brings a comprehensive new perspective to a growing body of evidence suggesting that mild…